Deciphera to be acquired by Japan’s Ono in all-cash deal valued at $2.4 billion

Deciphera specializes in kinase drug discovery, where kinases are enyzmes that help regulate cellular function.

Previous post Viking upsizes IPO, as more shareholders look to sell stock
Next post Cannabis company MedMen files for bankruptcy with about $411M in liabilities as its fortunes go up in smoke